Source link : https://www.newshealth.biz/health-news/adding-adt-to-high-dose-rt-benefits-some-prostate-cancers/
WASHINGTON — Combining short-term androgen deprivation therapy (ADT) with high-dose radiotherapy improves disease-free survival in men with intermediate-risk prostate cancer compared with high-dose radiotherapy alone, according to results of the phase 3 GETUG 14 trial. The 5-year disease-free survival rate was 84% in patients who received short-term ADT plus radiotherapy compared with 76% in those […]
Author : News Health
Publish date : 2024-10-08 06:53:48
Copyright for syndicated content belongs to the linked Source.
Categories